Pulmonology
Daga
$500
Har zuwa $5,000 ya danganta da cibiya
Tsawon lokaci na yau da kullum
7–21 days
Hada da gwaje-gwajen kafin tiyata
Asibitocin hadin gwiwa
1
An duba su don bayanan sakamako da takardar shaida
An bincika wannan abun ciki don daidaiton likitanci daga: Dr. Rodina Ainasoa · Marubuciyar Likitanci & Sadarwar Lafiya
Sarrafa zamani na chronic obstructive pulmonary disease da asma mai tsanani ta hanyar ingantaccen pharmacotherapy, gyarawa ta numfashi mai tsari, da ragewar girman huhu ta bronchoscopic mafi ƙarancin shiga — yana ba da ingantaccen ingancin rayuwa lokacin da maɓuɓɓugan al'ada suka kasa. Majinyata ta kasa da kasa suna amfana daga shawarwarin likitocin pulmonologist ƙwararru da dakunan gwaje-gwaje na aiki na huhu na zamani da farashi mai samu.
Ana daidaita al'amarinku da cibiya bisa bayanan sakamako na likitanci, ba talla ba. Muna tsara kowane mataki — daga gwaje-gwajen kafin tiyata zuwa biye-biye bayan jiyya — tare da mai tsara kulawa na musamman.
Kula da COPD da Asma
Kimar farashin hadin kai daga
ko aiko mana sako a kan WhatsApp
Ba a bukatar alkawari. Ana raba bayananku ne kawai da jam'iyyun da aka amince da su wadanda ke da hannu a hadin kan kulawar ku, bisa ka'idojin sirri da suka shafi.
Ana kula da COPD da asma ta hanyar matakai-matakai. Yawancin marasa lafiya suna samun sauƙi ta hanyar maganin shaƙa na yau da kullum, amma wasu kaɗan masu asma mai tsanani da ba a iya sarrafawa sosai suna iya cancanci ƙarin maganin halittu. Ga yadda hanyoyin biyu suke kwatanta.
| Sigar | Maganin Shaƙa na Yau da Kullum | Ƙarin Maganin Halittu |
|---|---|---|
| Abin da yake yi | Magungunan buɗe hanyoyin numfashi masu shaƙa (LABA/LAMA) da, idan an nuna buƙata, corticosteroid masu shaƙa suna buɗe hanyoyin numfashi kuma su rage kumburi kullum, bisa ga GOLD da GINA. | Wani ƙwayar rigakafi ta musamman da ake yi wa allura (misali anti-IgE ko anti-IL5/IL5R/IL4) tana kai hari kan wata hanyar kumburi ta musamman, ana ƙarawa sama da — ba maimakon — maganin shaƙa da aka inganta ba. |
| Wa yake dacewa | Hanyar farko ga kusan dukkan marasa lafiya masu COPD ko asma, bisa ga jagorar matakai-matakai na GOLD da GINA. | An keɓe shi don asma mai tsanani, wanda ke da wahalar magani, tare da tashin hankali mai gudana ko rashin sarrafa alamomi sosai duk da babban maganin shaƙa, kuma bayan an inganta magani ne kawai, bisa ga GINA. |
| Yadda ake fara shi | Likitan huhu ne ke rubuta shi kuma ya daidaita shi bisa sakamakon spirometry, nauyin alamomi, da tarihin tashin hankali. | Yana buƙatar tabbatar da alamomin da suka cancanta (kamar adadin eosinophil na jini ko FeNO, wanda aka auna fiye da sau ɗaya) kafin ƙwararre ya fara shi, bisa ga GINA. |
| Yadda ake bayarwa | Ana ba da kai da kansa kullum ko idan an bukata ta hanyar kayan shaƙa, a gida. | Ana bayarwa ta allura, yawanci kowane makonni biyu zuwa takwas ya danganta da nau'in maganin halittu, yawanci a wurin kula lafiya aƙalla a farko. |
| Manufa | Sarrafa alamomi na yau da kullum kuma a rage haɗarin tashin hankali a matsayin tushen kulawa na dogon lokaci. | Ƙara rage tashin hankali da amfani da corticosteroid ta baki ga marasa lafiya waɗanda cutar su ba a sarrafa ta ba da maganin yau da kullum kaɗai — ba madadin maganin shaƙa ba ne. |
COPD da asma cututtuka ne na dogon lokaci, don haka «magani» na nufin tsari na kulawa mai gudana maimakon aiki guda ɗaya. Matakan da ke ƙasa suna bayyana hanyar da aka saba amfani da ita; likitan huhunku zai daidaita tsarin bisa ga ganewar asali da tsananin cutar.
Bincike da spirometry
Ana auna aikin huhu ta hanyar spirometry don tabbatar da ganewar asali da auna tsanani, tare da bitar alamomi, abubuwan da ke haddasa cutar, tarihin tashin hankali, kuma — ga COPD — hali na shan taba, bisa ga GOLD da GINA.
Fara tsarin magani
Likitan huhunku yana fara muku maganin shaƙa na matakai-matakai da ya dace (magungunan buɗe hanyoyin numfashi, tare da ko ba tare da corticosteroid masu shaƙa ba), kuma ga COPD, ya tabbatar da tsarin dainawa shan taba da gyaran huhu inda ya dace.
Bibiya da daidaita kimar magani
Ana bitar martanin magani a alƙawuran bibiya, tare da daidaita dabarar amfani da kayan shaƙa, biyayya, da kimar magani bisa sarrafa alamomi da sabbin gwaje-gwajen aikin huhu.
Ƙara matakin magani idan an bukata
Idan alamomi ko tashin hankali ya ci gaba duk da an inganta maganin shaƙa, ƙwararrenku yana tantance ko ya dace a ƙara matakin magani — ga asma mai tsanani, gwajin alamomi don cancantar maganin halittu; ga wasu lamura na COPD ko asma, a mayar da su ga zaɓuɓɓukan bronkoskopi kamar rage girman huhu ta bronkoskopi ko thermoplasty na bronkiya.
Ana tantance martanin farko na magani; likitan huhunku yana duba ko alamomi da dabarar amfani da kayan shaƙa sun inganta kuma ya daidaita tsarin idan ba haka ba.
Ana yawanci yin cikakken tantancewa na sarrafa alamomi da aikin huhu, wanda ke jagorantar duk wani ƙari ko rage na magani bisa ga zagayen bitar GOLD da GINA.
Ga marasa lafiya da aka fara musu maganin halittu, ana bitar martani bisa hukuma kusan wata na huɗu kuma sake shi zuwa wata na goma sha biyu don yanke shawara akan ci gaba, bisa ga jagorar GINA; marasa lafiya na COPD da ke yin gyaran huhu yawanci suna kammala shirinsu na tsari a cikin wannan lokacin.
Saboda COPD da asma mai tsanani cututtuka ne na dogon lokaci, bibiya, bitar magunguna, da taimako na kaucewa abubuwan da ke haddasa cutar ko dainawa shan taba suna ci gaba har abada, tare da bitar ƙwararre na lokaci-lokaci da kulawa cikin sauri ga duk wata alama da ta ta'azzara.
Tushen bayani: Rahoton Global Initiative for Chronic Obstructive Lung Disease (GOLD) na 2026; rahotannin dabarun Global Initiative for Asthma (GINA) na 2024/2025. Tsarin kulawa na kowane mutum na iya bambanta kuma likitan huhunku ne ke jagoranta.
Haɗura da Iyakoki da Aka Sani
Tushen bayani: Rahoton Global Initiative for Chronic Obstructive Lung Disease (GOLD) na 2026; rahotannin dabarun Global Initiative for Asthma (GINA) na 2024/2025; Mayo Clinic; Cleveland Clinic. Babu tsarin magani da ke kawar da haɗari gaba ɗaya; likitan huhunku zai duba yanayin ku na musamman.
Bitar shari'a daga nesa
Ku raba sakamakon spirometry ɗinku, hotuna, tarihin alamomi, da magungunan da kuke amfani da su yanzu da tawagarmu ta daidaitawa, wadanda za su gaba da shari'ar ku don bitar farko ta likitan huhu na dacewarta da kulawa ko shiga tsakani a ƙasashen waje.
Haɗa ku da ƙwararre da cibiyar kulawa
Muna haɗa ku da wata cibiyar huhu da aka amince da ita mai ƙwarewa a kulawar COPD da asma mai tsanani, ciki har da fara maganin halittu ko zaɓuɓɓukan bronkoskopi inda ya dace ta fannin likitanci.
Kimar farashi da tsarin tafiya
Da zarar an duba shari'ar ku, muna ba da cikakken kimar farashi da ta ƙunshi shawarwari, gwaje-gwaje, da tsarin maganinku na farko, kuma muna taimakawa wajen tsara tsawon tafiya da ya dace da ko kulawarku tantancewa ce guda ɗaya, aiki ne, ko farkon magani mai gudana.
Fara magani da bibiya
Za ku halarci shawarwarinku da maganin farko — ko dai gyaran magani, fara maganin halittu, ko aikin bronkoskopi — tare da bibiya a asibiti ko na waje yadda ya dace kafin a ba ku izinin tafiya gida.
Bibiya da ci gaba da kulawa
Kafin ku tashi, ana raba bayanan maganinku da tsarin kulawa da likitan huhunku ko likitanku na gida domin su iya ci gaba da bibiya da kulawa, saboda COPD da asma mai tsanani suna buƙatar bibiya ta rayuwa duka.
Matsakaicin farashi da aka tsara a fadin cibiyoyinmu na hadin gwiwa. Farashin karshe ya danganta da tsananin yanayi da asibitin da aka zaba.
| Kasa | Matsakaicin farashi | idan aka kwatanta da mafi araha |
|---|---|---|
🇮🇳 India New Delhi · Chennai · Bengaluru · Hyderabad · Mumbai · Kochi | $1,000 | —chevron_right |
🇹🇷 Turkey Istanbul | $2,500 | +150%chevron_right |
Farashi kimantawa ne kuma yana bambanta bisa ga cikakkun bayanan aikin, asibiti, da tsananin yanayin likita. Nemi kimar musamman don al'amarinku.
Faridabad, India
Mafi babbar asibiti mai zaman kansa a Asiya — gadaje 2,600, dakunan tiyata 64, fannonin likitanci 81 a filin kadada 130 a Delhi NCR. An amince da NABH da NABL. Cibiyoyin kwarewa a oncology, tiyata ta zuciya, BMT, dashen gaɓoɓi, kimiyyar jijiya, da IVF.
NABH
NABL800+
Likitoci Kwararru
2,600+
Gadaje
BLVR with endobronchial valves is suitable for patients with severe emphysema (COPD GOLD stage III-IV) who have significant hyperinflation, are non-responsive to maximum inhaler therapy, and have no significant collateral ventilation in the target lobe. Eligibility is confirmed through a CT scan with fissure analysis and a bronchoscopic Chartis assessment. Your pulmonologist will review your existing scans and lung function reports remotely before travel to confirm suitability.
Babu kudi. Babu alkawari.
Asibitocinmu na hadin gwiwa ne suke biyanmu — ba majinyata ba. Kuna samun daidaita likitanci mai tsari, bayyana farashi, da cikakken tsari ba tare da kudi a kanku ba.
